Efficacy and safety of calcium, magnesium, potassium, and sodium oxybates (lower-sodium oxybate [LXB]; JZP-258) in a placebo-controlled, double-blind, randomized withdrawal study in adults with narcolepsy with cataplexy

STUDY OBJECTIVES: Evaluate efficacy and safety of lower-sodium oxybate (LXB), a novel oxybate medication with 92% less sodium than sodium oxybate (SXB). METHODS: Adults aged 18–70 years with narcolepsy with cataplexy were eligible. The study included a ≤30-day screening period; a 12-week, open-label...

Descripción completa

Detalles Bibliográficos
Autores principales: Bogan, Richard K, Thorpy, Michael J, Dauvilliers, Yves, Partinen, Markku, Del Rio Villegas, Rafael, Foldvary-Schaefer, Nancy, Skowronski, Roman, Tang, Lihua, Skobieranda, Franck, Šonka, Karel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Neurological Disorders
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7953213/
https://www.ncbi.nlm.nih.gov/pubmed/33184650
http://dx.doi.org/10.1093/sleep/zsaa206

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7953213/
https://www.ncbi.nlm.nih.gov/pubmed/33184650
http://dx.doi.org/10.1093/sleep/zsaa206

Ejemplares similares